Etoricoxib CAS: 202409-33-4
| Product Parameters | |
|---|---|
| Catalog No. | BA7V1T |
| CAS.RN | 202409-33-4 |
| Molecular Formula | C18H15ClN2O2S |
| Molecular Weight | 358.8 g/mol |
| Purity | NLT 98% |
Product Overview
Etoricoxib is a selective COX-2 inhibitor widely used in the field of nonsteroidal anti-inflammatory drugs (NSAIDs), primarily for the treatment of inflammatory diseases such as osteoarthritis, rheumatoid arthritis, and acute pain. As an active pharmaceutical ingredient (API), etoricoxib is suitable for multiple stages of drug development, small-scale preparation, pilot-scale amplification, and commercial production. It exhibits excellent chemical stability and biological activity, meeting the stringent requirements of the pharmaceutical industry for high-purity, high-quality APIs, and is a crucial foundational material for innovative drug development and generic drug production.
Applications
- Drug development for the treatment of osteoarthritis and rheumatoid arthritis
- Formulation process development of nonsteroidal anti-inflammatory drugs (NSAIDs)
- Supply of active pharmaceutical ingredients (APIs) for preclinical and clinical trials
- Raw material procurement and custom synthesis for generic and innovative drugs
- Preparation of pharmaceutical intermediates and active pharmaceutical ingredients
Quality & Supply Capability
English Name: Etoricoxib Properties: White to off-white crystalline powder, readily soluble in organic solvents such as ethanol and methanol, exhibiting good thermal and chemical stability. Its core functional group is a benzothiazole ring structure, meeting pharmaceutical-grade API standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized mass production. We can flexibly adjust supply solutions according to customers' specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in process development, route optimization, and project transformation, ensuring a seamless transition from R&D to mass production.
Why Choose Bioncan
Focused on pharmaceutical raw materials, with extensive experience supplying Etoxicox. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity limits, and packaging specifications according to customer requirements. Provides supporting process optimization technology to help customers achieve efficient and stable process development and project commercialization.
Intermediates of Etoricoxib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA7V1T | Etoricoxib API | 202409-33-4 |
| BK92H2 | 4-Methylthiophenylacetic acid | 16188-55-9 |
| BK7R4V | 4-Methylsulphonylphenylacetic acid | 90536-66-6 |
| BK4EL1 | 1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone | 221615-72-1 |
| BK92BL | 2-(4-Methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethanone | 221615-75-4 |
| BK132J | 2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate | 249561-98-6 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 202409-33-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.